1-6 of 6
Juliana M.L. Biondo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Adherence and Persistence to Emicizumab Using a National US Claims Database

Amy D. Shapiro, Robert Schuldt, Zhiyu Xia, Carmen Ng, Lucy Lee, Juliana M.L. Biondo, Janet S Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 3699.
https://doi.org/10.1182/blood-2024-199645
Published: 2024
Journal Articles

Real-World Experience with Emicizumab for Hemophilia a from the Physician Perspective Based on Survey Data

Michael Recht, Hanna Salehi, Chris Blazos, Sophie Lai, Ella Morton, Lucy Lee, Juliana M.L. Biondo, Janet S Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 5078.
https://doi.org/10.1182/blood-2024-200784
Published: 2024
Journal Articles

Fixed-Duration Subcutaneous Mosunetuzumab Is Active and Has a Manageable Safety Profile in Patients with Previously Untreated, Low-Tumor Burden Follicular Lymphoma: Updated Results from the Phase II Morningsun Study

John M. Burke, Ian W. Flinn, L. Elizabeth Budde, Aung M. Tun, Steven Liu, Juliana M.L. Biondo, Prachi Jani, Mei Wu, Yong Mun, Vivek S. Chopra, Jessica M. Grindheim, Dana Farinella, Jose C. Villasboas Bisneto
Journal: Blood
Blood (2024) 144 (Supplement 1): 3008.
https://doi.org/10.1182/blood-2024-194604
Published: 2024
Journal Articles

Real-World Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First-Line (1L) Therapy in the United States (US)

Anthony R. Mato, Arliene Ravelo, Tu My To, Robert Schuldt, Juliana M.L. Biondo
Journal: Blood
Blood (2021) 138 (Supplement 1): 4086.
https://doi.org/10.1182/blood-2021-148472
Published: 2021
Journal Articles

Zanubrutinib, Obinutuzumab, and Venetoclax in Chronic Lymphocytic Leukemia: Early MRD Kinetics Define a High-Risk Patient Cohort with Delayed Bone Marrow Undetectable MRD and Earlier Post-Treatment MRD Recurrence

Jacob D. Soumerai, Anthony R. Mato, Ahmet Dogan, Venkatraman Seshan, Erel Joffe, Kelsey Flaherty, Jason Carter, Ephraim P Hochberg, Jeffrey A Barnes, Audrey Hamilton, Jeremy S. Abramson, Connie Lee Batlevi, Matthew J. Matasar, Ariela Noy, Colette Owens, M. Lia Palomba, Anita Kumar, Tak Takvorian, Ai Ni, Morgan Choma, Chaya Friedman, Puja Chadha, Elizabeth Simkins, Jade Ruiters, Sidney Sechio, Daneal Portman, Natascha Nolet, Neena Mahajan, Rosalba Martignetti, Joanna Mi, Krista J Scorsune, Julia M Lynch, Brianne McGree, Stephanie Y Hughes, Clare Grieve, Lindsey E. Roeker, Meghan C. Thompson, P. Connor Johnson, Mikhail Roshal, Jane Huang, Juliana M.L. Biondo, Jenny Qun Wu, Allison P. Jacob, Omar Abdel-Wahab, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 138 (Supplement 1): 3753.
https://doi.org/10.1182/blood-2021-150961
Published: 2021
Journal Articles

Majic: A Phase 3 Prospective, Multicenter, Randomized, Open-Label Trial of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Matthew S. Davids, Anthony R. Mato, Juliette Hum, Susana Wargo, Ugochinyere Emeribe, Mina Shahkarami, Kevin Sokolowski, Juliana M.L. Biondo, Sarang Abhyankar, Rick Hermann, Jeff P. Sharman
Journal: Blood
Blood (2021) 138 (Supplement 1): 1553.
https://doi.org/10.1182/blood-2021-148155
Published: 2021